i never could understand why GTC was unable to recover this loss from the contractor...
terms of the contract...? the ability of contractor to pay...? I dunno.
in my mind it appears GTC has been pushing from its inception to be recognized by the US regulators (transgenics platform) -i.e. ATryn approval by the FDA.
No doubt this approval is an important milestone. If approval comes... what is the value to the company, beyond ATryn sales and milestone payment?
Will / could this approval open doors / opportunities that were previously closed?
Market Data 
Markets 
AI
